Product Name
CD19 Recombinant Rabbit Monoclonal Antibody [PSH13-44] - BSA and Azide free
Antibody Type
Recombinant Rabbit monoclonal Antibody
Immunogen
Recombinant protein within human CD19 aa 1-291.
Target Molecular Weight
Predicted band size: 61 kDa
Positive Control
Raji cell lysate, Ramos cell lysate, Daudi cell lysate, Raji, Ramos, human peripheral blood cells.
Storage Instructions
Store at 2-8℃. Avoid freeze.
Purification Method
Protein A affinity purified.
Function
B-lymphocyte antigen CD19, also known as CD19 molecule (Cluster of Differentiation 19), B-Lymphocyte Surface Antigen B4, T-Cell Surface Antigen Leu-12 and CVID3 is a transmembrane protein that in humans is encoded by the gene CD19. In humans, CD19 is expressed in all B lineage cells. Contrary to some early doubts, human plasma cells do express CD19. CD19 plays two major roles in human B cells: on the one hand, it acts as an adaptor protein to recruit cytoplasmic signaling proteins to the membrane; on the other, it works within the CD19/CD21 complex to decrease the threshold for B cell receptor signaling pathways. Due to its presence on all B cells, it is a biomarker for B lymphocyte development, lymphoma diagnosis and can be utilized as a target for leukemia immunotherapies.
Background References
1. Pecher AC et al. CD19-Targeting CAR T Cells for Myositis and Interstitial Lung Disease Associated With Antisynthetase Syndrome. JAMA. 2023 Jun
2. Fischbach F et al. CD19-targeted chimeric antigen receptor T cell therapy in two patients with multiple sclerosis. Med. 2024 Jun
Subcellular Location
Cell membrane, Membrane raft.
Synonyms
Antibody deficiency due to defect in CD19 antibody
Antibody deficiency due to defect in CD19, included antibody
AW495831 antibody
B lymphocyte antigen CD19 antibody
B lymphocyte surface antigen B4 antibody
B-lymphocyte antigen CD19 antibody
B-lymphocyte surface antigen B4 antibody
B4 antibody
CD19 antibody
CD19 antigen antibody
Expand
Antibody deficiency due to defect in CD19 antibody
Antibody deficiency due to defect in CD19, included antibody
AW495831 antibody
B lymphocyte antigen CD19 antibody
B lymphocyte surface antigen B4 antibody
B-lymphocyte antigen CD19 antibody
B-lymphocyte surface antigen B4 antibody
B4 antibody
CD19 antibody
CD19 antigen antibody
CD19 molecule antibody
Cd19 protein antibody
CD19_HUMAN antibody
CVID3 antibody
Differentiation antigen CD19 antibody
Leu 12 antibody
Leu-12 antibody
Leu12 antibody
MGC109570 antibody
MGC12802 antibody
T-cell surface antigen Leu-12 antibody
Collapse
-
☑ Relative expression (RE)
This data was developed using HA723533, the same antibody clone in a different buffer formulation.
Western blot analysis of CD19 on different lysates with Rabbit anti-CD19 antibody (HA723533) at 1/50,000 dilution.
Lane 1: Raji cell lysate
Lane 2: Ramos cell lysate
Lane 3: 293T cell lysate (negative)
Lane 4: Daudi cell lysate
Lane 5: K-562 cell lysate (negative)
Lysates/proteins at 20 µg/Lane.
Predicted band size: 61 kDa
Observed band size: 100 kDa
Exposure time: 25 seconds; ECL: K1801;
4-20% SDS-PAGE gel.
Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (HA723533) at 1/50,000 dilution was used in primary antibody dilution (K1803) at 4℃ overnight. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1/50,000 dilution was used for 1 hour at room temperature.
-
☑ Relative expression (RE)
This data was developed using HA723533, the same antibody clone in a different buffer formulation.
Immunocytochemistry analysis of Raji (positive) and 293T (negative) labeling CD19 with Rabbit anti-CD19 antibody (HA723533) at 1/2,000 dilution.
Cells were fixed in 4% paraformaldehyde for 15 minutes at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 15 minutes at room temperature, then blocked with 1% BSA in 10% negative goat serum for 1 hour at room temperature. Cells were then incubated with Rabbit anti-CD19 antibody (HA723533) at 1/2,000 dilution in 1% BSA in PBST overnight at 4 ℃. Goat Anti-Rabbit IgG H&L (iFluor™ 488, HA1121) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI.
Beta tubulin (HA601187, red) was stained at 1/100 dilution overnight at +4℃. Goat Anti-Mouse IgG H&L (iFluor™ 594, HA1126) was used as the secondary antibody at 1/1,000 dilution.
-
☑ Relative expression (RE)
This data was developed using HA723533, the same antibody clone in a different buffer formulation.
Flow cytometric analysis of K-562 (left, negative) and Ramos (right, positive) cells labeling CD19.
Cells were washed twice with cold PBS and resuspend. Then stained with the primary antibody (HA723533, 1/5,000) (red) compared with Rabbit IgG Isotype Control (green). After incubation of the primary antibody at +4℃ for an hour, the cells were stained with a iFluor™ 488 conjugate-Goat anti-Rabbit IgG Secondary antibody (HA1121) at 1/1,000 dilution for 30 minutes at +4℃. Unlabelled sample was used as a control (cells without incubation with primary antibody; black).
-
This data was developed using HA723533, the same antibody clone in a different buffer formulation.
Flow cytometric analysis of human peripheral blood cells labeling CD19 (HA723533), counterstained with CD3-PE.
Cells were washed twice with cold PBS and resuspend. Then stained with the primary antibody (HA723533, 1/1,000). After incubation of the primary antibody at +4℃ for an hour, the cells were stained with a iFluor™ 488 conjugate-Goat anti-Rabbit IgG Secondary antibody (HA1121) at 1/1,000 dilution for 30 minutes at +4℃.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"